Long Non-coding RNA Fer-1-like Protein 4 Suppresses Oncogenesis and Exhibits Prognostic Value by Associating with MiR-106a-5p in Colon Cancer

Overview

Journal Cancer Sci

Specialty Oncology

Date 2015 Jul 31

PMID 26224446

Citations 75

Authors

Ben Yue

Bo Sun

Chenchen Liu

Senlin Zhao

Dongyuan Zhang

Fudong Yu

Dongwang Yan

Affiliations

Soon will be listed here.

Abstract

Novel long non-coding RNA Fer-1-like protein 4 (FER1L4) has been confirmed to play crucial regulatory roles in tumor progression. It exerts an impact on tumor suppression and functions as a competing endogenous RNA (ceRNA) by sponging miR-106a-5p in gastric cancer. However, its clinical significance in colon cancer is completely unknown. The aim of the present study was to annotate the role of FER1L4 and its clinical value in colon cancer. The results showed the aberrant expression of FER1L4 and miR-106a-5p in colon cancer tissues. In addition, significant negative correlation between FER1L4 and miR-106a-5p expression levels was observed. Among the colon cancer cell lines, FER1L4 levels were relatively lower, with concurrent high levels of miR-106a-5p. Restoration of FER1L4 decreased the expression of miR-106a-5p, and had a significant influence on colon cancer cell proliferation, migration and invasion. The FER1L4 expression was correlated with depth of tumor invasion, lymph node metastasis, vascular invasion and clinical stage. Moreover, striking differences in overall survival and disease-free survival were observed for the cases with both low FER1L4 expression and high miR-106a-5p expression compared with cases with high FER1L4 expression and low miR-106a-5p expression. Circulating FER1L4 and miR-106a-5p levels were decreased and increased, respectively, in colon cancer patients after surgery. Our findings indicated that FER1L4 could exert a tumor suppressive impact on colon cancer, which at least, in part, through suppressing miR-106a-5p expression, and depletion of FER1L4, alone or combined with overexpression of miR-106a-5p, is predictive of poor prognosis in colon cancer and may play a crucial role in cancer prevention and treatment.

Citing Articles

Zhang C, Sun D, Zhou H, Liu C, Ruan J, Kang J Discov Oncol. 2025; 16(1):75.

PMID: 39838125 PMC: 11751285. DOI: 10.1007/s12672-025-01765-3.

Fer-1 like family member 4 pseudogene: novel potential diagnostic and prognostic biomarker for cutaneous melanoma.

Kolenda T, Guglas K, Stasiak M, Poter P, Kozlowska-Maslon J, Bialas P EXCLI J. 2025; 23:1375-1396.

PMID: 39764216 PMC: 11701299. DOI: 10.17179/excli2024-7719.

Long non‑coding RNAs as diagnostic and prognostic biomarkers for colorectal cancer (Review).

Lin Y, Zhao W, Pu R, Lv Z, Xie H, Li Y Oncol Lett. 2024; 28(4):486.

PMID: 39185489 PMC: 11342420. DOI: 10.3892/ol.2024.14619.

The functions and mechanisms of long non-coding RNA in colorectal cancer.

Lin Y, Zhao W, Lv Z, Xie H, Li Y, Zhang Z Front Oncol. 2024; 14:1419972.

PMID: 39026978 PMC: 11254705. DOI: 10.3389/fonc.2024.1419972.

Exploring miRNA Profiles in Colon Cancer: A Focus on miR101-3p, miR106a-5p, and miR326.

Talvan C, Talvan E, Mohor C, Budisan L, Grecu V, Mihalache M Cancers (Basel). 2024; 16(12).

PMID: 38927989 PMC: 11201595. DOI: 10.3390/cancers16122285.

References

Wu Z, Wang X, Tang H, Jiang T, Chen J, Lu S . Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep. 2014; 32(1):395-402. DOI: 10.3892/or.2014.3186. View

Gibb E, Brown C, Lam W . The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011; 10:38. PMC: 3098824. DOI: 10.1186/1476-4598-10-38. View

Foltran L, De Maglio G, Pella N, Ermacora P, Aprile G, Masiero E . Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncol. 2015; 11(4):629-40. DOI: 10.2217/fon.14.279. View

Yuan J, Yang F, Wang F, Ma J, Guo Y, Tao Q . A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25(5):666-81. DOI: 10.1016/j.ccr.2014.03.010. View

Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi Y . Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep. 2014; 4:6088. PMC: 4133709. DOI: 10.1038/srep06088. View

Clark M, Johnston R, Inostroza-Ponta M, Fox A, Fortini E, Moscato P . Genome-wide analysis of long noncoding RNA stability. Genome Res. 2012; 22(5):885-98. PMC: 3337434. DOI: 10.1101/gr.131037.111. View

Zhi F, Shao N, Wang R, Deng D, Xue L, Wang Q . Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro Oncol. 2014; 17(3):383-91. PMC: 4483096. DOI: 10.1093/neuonc/nou169. View

Liu Z, Shao Y, Tan L, Shi H, Chen S, Guo J . Clinical significance of the low expression of FER1L4 in gastric cancer patients. Tumour Biol. 2014; 35(10):9613-7. DOI: 10.1007/s13277-014-2259-4. View

Zhi F, Zhou G, Shao N, Xia X, Shi Y, Wang Q . miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK. PLoS One. 2013; 8(8):e72390. PMC: 3754986. DOI: 10.1371/journal.pone.0072390. View

10.

Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. DOI: 10.3322/caac.20073. View

11.

Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z . LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013; 41(9):4976-87. PMC: 3643595. DOI: 10.1093/nar/gkt182. View

12.

Shao Y, Chen H, Jiang X, Chen S, Li P, Ye M . Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol. 2014; 35(10):9591-5. DOI: 10.1007/s13277-014-2243-z. View

13.

Muller S, Nowak K . Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. Biomed Res Int. 2014; 2014:948408. PMC: 4054612. DOI: 10.1155/2014/948408. View

14.

Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X . Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014; 5(14):5439-52. PMC: 4170615. DOI: 10.18632/oncotarget.2118. View

15.

Li J, Chen Z, Tian L, Zhou C, He M, Gao Y . LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut. 2014; 63(11):1700-10. PMC: 4215280. DOI: 10.1136/gutjnl-2013-305806. View

16.

Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y . CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010; 38(16):5366-83. PMC: 2938198. DOI: 10.1093/nar/gkq285. View

17.

Guttman M, Rinn J . Modular regulatory principles of large non-coding RNAs. Nature. 2012; 482(7385):339-46. PMC: 4197003. DOI: 10.1038/nature10887. View

18.

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

19.

Ma M, Chu B, Zhang Y, Weng M, Qin Y, Gong W . Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 2015; 6:e1583. PMC: 4669740. DOI: 10.1038/cddis.2014.541. View

20.

Song H, Sun W, Ye G, Ding X, Liu Z, Zhang S . Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013; 11:225. PMC: 3848969. DOI: 10.1186/1479-5876-11-225. View